Herbalife (NYSE:HLF) Reaches New 12-Month High – Should You Buy?

Herbalife Ltd (NYSE:HLF) shares reached a new 52-week high on Thursday . The stock traded as high as $19.26 and last traded at $19.3940, with a volume of 57241 shares changing hands. The stock had previously closed at $16.54.

Key Stories Impacting Herbalife

Here are the key news stories impacting Herbalife this week:

• Positive Sentiment: Cristiano Ronaldo bought a 10% stake in Herbalife’s Pro2col wellness platform (reported $7.5M investment). The celebrity backing is being viewed as a major marketing and distribution catalyst for the digital personalized-nutrition product, and markets reacted strongly to the announcement. Herbalife Announces Cristiano Ronaldo Invests $7.5 Million in Pro2col™ Technology, Acquires 10% Equity Stake
• Positive Sentiment: Q4: net sales grew ~6.3% YoY to about $1.28B and adjusted EBITDA came in above the company’s guidance — supporting the narrative of top‑line momentum and improved cash generation. Herbalife Delivers Fourth Quarter and Full-Year Net Sales Growth, Net Sales and Adjusted EBITDA1 Exceed Guidance
• Neutral Sentiment: The company issued FY2026 revenue guidance roughly in line with Street expectations (about $5.1B–$5.3B) and guided Q1 revenue near prior consensus — guidance neither surprises to the upside nor materially weakens the outlook. Herbalife Delivers Fourth Quarter and Full-Year Net Sales Growth, Net Sales and Adjusted EBITDA1 Exceed Guidance
• Negative Sentiment: Earnings miss and weaker profitability: reported EPS of $0.45 missed the consensus (~$0.48) and underlying profitability measures (operating profit and net income) declined year‑over‑year, which underscores margin pressure despite revenue growth. Investors should weigh the top-line strength against the earnings miss and lower net income. Herbalife Ltd. (HLF) stock rises on Q4 2025 Earnings

Analyst Upgrades and Downgrades

Several brokerages have commented on HLF. Weiss Ratings reiterated a “hold (c)” rating on shares of Herbalife in a research note on Thursday, January 22nd. Maxim Group assumed coverage on Herbalife in a research note on Tuesday, January 6th. They issued a “buy” rating and a $20.00 price objective on the stock. Wall Street Zen raised Herbalife from a “hold” rating to a “buy” rating in a research report on Friday, November 28th. Citigroup reaffirmed a “buy” rating on shares of Herbalife in a research report on Thursday. Finally, Argus set a $15.00 price objective on Herbalife in a report on Wednesday, November 26th. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, Herbalife currently has an average rating of “Moderate Buy” and a consensus target price of $15.80.

Herbalife Price Performance

The stock has a market capitalization of $2.02 billion, a P/E ratio of 6.24 and a beta of 0.84. The stock has a fifty day moving average price of $15.39 and a 200 day moving average price of $11.59.

Herbalife (NYSE:HLF) last released its quarterly earnings data on Wednesday, February 18th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.03). Herbalife had a net margin of 6.47% and a negative return on equity of 29.84%. The company had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.24 billion. During the same quarter in the previous year, the firm posted $0.36 earnings per share. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. Research analysts anticipate that Herbalife Ltd will post 1.57 earnings per share for the current year.

Institutional Trading of Herbalife

A number of hedge funds and other institutional investors have recently bought and sold shares of HLF. AQR Capital Management LLC lifted its stake in Herbalife by 236.8% in the 1st quarter. AQR Capital Management LLC now owns 133,245 shares of the company’s stock worth $1,150,000 after purchasing an additional 93,686 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Herbalife by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,964 shares of the company’s stock worth $517,000 after purchasing an additional 2,523 shares during the period. Empowered Funds LLC raised its position in shares of Herbalife by 12.9% in the first quarter. Empowered Funds LLC now owns 30,301 shares of the company’s stock worth $261,000 after buying an additional 3,474 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Herbalife by 3.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 210,904 shares of the company’s stock valued at $1,820,000 after buying an additional 6,747 shares during the period. Finally, Vanguard Personalized Indexing Management LLC purchased a new position in Herbalife during the second quarter worth about $103,000.

Herbalife Company Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.